Finance

http://s.erious.ly
Posts tagged "agn"
Publishers / Seeking Alpha - Transcripts

Allergan Management Discusses Q3 2011 Results – Earnings Call Transcript

by SeekingAlpha.com on Oct 26, 2011 • No Comments

Allergan (AGN)

Q3 2011 Earnings Call

October 26, 2011 11:00 am ET

Executives

James M. Hindman - Chief Financial Officer

Jeffrey L. Edwards - Chief Financial Officer and Executive Vice President of Finance & Business Development

Joann Bradley - IR

David E.I. Pyott - Chairman, Chief Executive officer and President

Scott M. Whitcup - Chief Scientific Officer and...

Publishers / Seeking Alpha - Transcripts

Allergan Management Discusses Q2 2011 Results – Earnings Call Transcript

by SeekingAlpha.com on Aug 3, 2011 • No Comments

Allergan (AGN)

Q2 2011 Earnings Call

August 03, 2011 11:00 am ET

Executives

Scott Whitcup - Chief Scientific Officer and Executive Vice President of Research & Development

David Pyott - Chairman, Chief Executive officer and President

James Hindman - Senior Vice President, Treasury, Risk and Investor Relations

Jeffrey Edwards - Chief Financial Officer and Executive Vice President...

Blogging Stocks / Publishers

Analyst Calls: AMTD, COG, DO, F, GM, HUM, LEA, MMI, NKE, SI, TRW …

by Eric Buscemi on Mar 18, 2011 • No Comments
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Ford Motor (F), General Motors (GM), NIKE, Inc'B' (NKE), TD AmeriTrade Holding (AMTD), Analyst InitiationsAnalyst Upgrades Siemens (SI) to buy from hold at Deutsche Bank. Diamond O...
footnoted.org / Publishers

At Hospira, a “perfect fit” in pay…

by Sonya Hubbard on Mar 10, 2011 • No Comments
Today’s post isn’t really another one about Allergan (AGN), but – coincidentally – a company that hired away one of its executives. The link between the two companies is F. Michael Ball, who on March 2 advised Allergan that “he would retire from the Company and resign from his position as President, effective March 27,...
footnoted.org / Publishers

Tightening the belt (or not) at Allergan…

by Theo Francis on Mar 9, 2011 • No Comments
When tough times hit, and companies and individuals alike cut back on spending, usually discretionary and big-ticket items are the first to go. As you might imagine, that can be bad news for a lot of companies — particularly one marketing breast implants, Botox and the modern equivalent of stomach stapling. And so it is,...
Publishers / Seeking Alpha - Transcripts

Allergan CEO Discusses Q4 2010 Earnings Call Transcript

by SeekingAlpha.com on Feb 2, 2011 • No Comments

Allergan (AGN)

Q4 2010 Earnings Call

February 02, 2011 11:00 am ET

Executives

Scott Whitcup - Chief Scientific Officer and Executive Vice President of Research & Development

James Hindman - Senior Vice President, Treasury, Risk and Investor Relations

Jeffrey Edwards - Chief Financial Officer and Executive Vice President of Finance & Business Development

David Pyott - Chairman, Chief Executive...

footnoted.org / Publishers

The executive kennel club…

by Michelle Leder on Nov 5, 2010 • No Comments
Footnoted world headquarters recently underwent a temporary relocation moving from Peekskill to Chicago. And, because the brain behind footnoted is such a critical part of the team, Kumara’s care and comfort were a key factor as we searched for a place to live. It’s one of the primary reasons that we moved into an apartment...
Publishers / Seeking Alpha - Transcripts

Allergan Q3 2010 Earnings Call Transcript

by SeekingAlpha.com on Nov 1, 2010 • No Comments

Allergan (AGN)

Q3 2010 Earnings Call

November 01, 2010 11:00 am ET


Complete Story »
Blogging Stocks / Publishers

Allergan’s Botox Approved for Migraine Treatment

by Brent Archer on Oct 18, 2010 • No Comments
Filed under: Major Movement, Good news, Allergan (AGN), Options, Technical AnalysisAllergan (AGN - option chain) shares are rising today after the company announced FDA approval of Allergan's Botox for use as a treatment for chronic Migraine headaches ...
Blogging Stocks / Publishers

Allergan Rallies on News of License Agreement

by Mark Fightmaster on Aug 25, 2010 • No Comments
Filed under: Allergan (AGN)As the opening bell sounded and stocks got off to a sluggish start, I decided to take a look for stocks that got off to a fast start. One of those stocks is Botox-maker Allergan (AGN). In early trading, the pharmaceutical fir...
Publishers / Seeking Alpha - Transcripts

Allergan Q2 2010 Earnings Call Transcript

by SeekingAlpha.com on Aug 2, 2010 • No Comments

Allergan (AGN)

Q2 2010 Earnings Call

August 02, 2010 11:00 am ET


Complete Story »
Blogging Stocks / Publishers

Allergan Second Quarter Earnings Preview

by Michael Fowlkes on Jul 30, 2010 • No Comments
Filed under: Earnings Reports, Forecasts, Products and Services, Competitive Strategy, Allergan (AGN)Drug manufacturer Allergan, Inc. (AGN) will be reporting its second quarter results on Monday, with analysts expecting to see an 8% earnings increase f...

Follow seriouslyfinace on Twitter!

Follow seriouslyfinance on FaceBook

Sponsorship

Twitter on #stocks and #finance

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

© 2010 Finance. All Rights Reserved.
Powered by WordPress.

Designed by WPSHOWER